FOA, PAOLO
FOA, PAOLO
Dipartimento di Oncologia ed Emato-Oncologia
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
2019 U. De Giorgi, G. Cartenì, D. Giannarelli, U. Basso, L. Galli, E. Cortesi, C. Caserta, S. Pignata, R. Sabbatini, A. Bearz, S. Buti, G. Lo Re, A. Berruti, S. Bracarda, F. Cognetti, F. Rastelli, G. Fornarini, C. Porta, D. Turci, C.N. Sternberg, G. Procopio, A. Falcone, F. Roila, S. Cascinu, U. Tirelli, L. Giustini, A. Sobrero, F. Cappuzzo, D. Tassinari, R. Passalacqua, A. Pazzola, G. Surico, M. Maio, G. Benedetti, C. Barone, V. Adamo, E. Ricevuto, A. De Censi, M. Spada, G. Tonini, C. Pinto, L. Ciuffreda, E.M. Ruggeri, C. Bengala, V. Scotti, D. Fagnani, A. Bonetti, M. Mitterer, F. Castiglione, P. Bidoli, F. Ferraù, L. Crinò, A. Frassoldati, P. Marchetti, E. Mini, A. Scoppola, C. Verusio, A. Favaretto, F. Di Costanzo, G. Fasola, M. Merlano, F. Artioli, A. Di Leo, S. Romito, A. Maestri, C. Giannitto Giorgio, M.T. Ionta, F. Verderame, G. Zampa, G. Numico, M. Minelli, P. Tagliaferri, P. Foa, G. Palmiotti, S. De Placido, R. Mattioli, F. Iuliano, E. Defraia, S. Siena, M. Clerico, L. Salvagno, G.L. Ceresoli, A. Bernardo, M. Di Lieto, M. Moroni, M. Maisano, M. Scartozzi, G. Scagliotti, M. Sorarù, S. Pepe, A. Scaltriti, V. Gebbia, E. Testa, V. Lorusso, R. Bordonaro, G. De Signoribus, N. Tedde, A. Santoro, G. Francini, G. Aondio
An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature
2016 D. Ferrari, C. Codecà, G. Viale, B. Bocci, F. Broggio, F. Crepaldi, M. Violati, A. Luciani, D. Bauer, L. Moneghini, G. Bulfamante, P. Foa, G. Viale
Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration
2016 D. Ferrari, C. Codecà, B. Bocci, F. Crepaldi, M. Violati, G. Viale, C. Careri, S. Caldiera, V. Bordin, A. Luciani, S. Zonato, G. Cassinelli, P. Foa
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study
2015 A. Santoro, V. Gebbia, T. Pressiani, A. Testa, N. Personeni, E. Arrivas Bajardi, P. Foa, A. Buonadonna, K. Bencardino, C. Barone, D. Ferrari, A. Zaniboni, M.C. Tronconi, G. Carteni, M. Milella, A. Comandone, S. Ferrari, L. Rimassa
Estimating the risk of chemotherapy toxicity in older patients with cancer : the role of the Vulnerable Elders Survey-13 (VES-13)
2015 A. Luciani, L. Biganzoli, G. Colloca, C. Falci, B. Castagneto, I. Floriani, N. Battisti, L. Dottorini, D. Ferrari, P. Fiduccia, E. Zafarana, F. Del Monte, F. Galli, S. Monfardini, P. Foa
Multimodality treatment of osteosarcoma of the jaw : a single institution experience
2014 D. Ferrari, C. Codecà, N. Battisti, F. Broggio, F. Crepaldi, M. Violati, C. Bertuzzi, L. Dottorini, S. Caldiera, A. Luciani, L. Moneghini, F. Biglioli, G. Cassinelli, A. Morabito, P. Foa
miR-296/scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo
2014 F. Savi, I. Forno, A. Faversani, A. Luciani, S. Caldiera, S. Gatti, P. Foa, D. Ricca, G. Bulfamante, V. Vaira, S. Bosari
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma
2013 L. Rimassa, T. Pressiani, C. Boni, C. Carnaghi, E. Rota Caremoli, S. Fagiuoli, P. Foa, S. Salvagni, E. Cortesi, M.C. Tronconi, N. Personeni, S. Bozzarelli, M.C. Banzi, S. Fanello, F. Romano Lutman, L. Giordano, A. Santoro
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
2013 J.B. Vermorken, J. Stöhlmacher Williams, I. Davidenko, L. Licitra, E. Winquist, C. Villanueva, P. Foa, S. Rottey, K. Skladowski, M. Tahara, V.R. Pai, S. Faivre, C.R. Blajman, A.A. Forastiere, B.N. Stein, K.S. Oliner, Z. Pan, B.A. Bach
Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA)
2013 A. Luciani, L. Dottorini, N. Battisti, C. Bertuzzi, S. Caldiera, I. Floriani, S. Zonato, D. Ferrari, P. Foa
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients
2012 F. Alongi, M. Bignardi, I. Garassino, S. Pentimalli, R. Cavina, P. Mancosu, G. Reggiori, A. Poletti, D. Ferrari, P. Foa, A. Bigoni, A. Dragonetti, P. Salvatori, O. Spahiu, A. Fogliata, L. Cozzi, A. Santoro, M. Scorsetti
Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population
2012 D. Ferrari, C. Codecà, C. Bertuzzi, F. Broggio, F. Crepaldi, A. Luciani, I. Floriani, M. Ansarin, F. Chiesa, D. Alterio, P. Foa
Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial
2011 M. Henke, M. Alfonsi, P. Foa, J. Giralt, E. Bardet, L. Cerezo, M. Salzwimmer, R. Lizambri, L. Emmerson, M.G. Chen, D. Berger
Reply to M.J. Molina-Garrido et al
2011 A. Luciani, P. Foa
Interventi di supporto per pazienti oncologici : un'esperienza di psicodramma classico
2010 E. Vegni, N. Tomasoni, I. Fossati, G. Felisati, P. Foa, E.A. Moja
Detecting disabilities in older patients with cancer : comparison between comprehensive geriatric assessment and vulnerable elders survey-13
2010 A. Luciani, G. Ascione, C. Bertuzzi, D. Marussi, C. Codecà, G. DI MARIA, S.E. Caldiera, I. Floriani, S. Zonato, D. Ferrari, P. Foa
Reply to C. Falci et al
2010 A. Luciani, I. Floriani, P. Foa
A review on the treatment of relapsed/metastatic head and neck cancer
2009 D. Ferrari, C. Codecà, J. Fiore, A. Luciani, P. Foa
Clinical analysis of multiple primary malignancies in the elderly
2009 A. Luciani, G. Ascione, D. Marussi,S. Oldani, S. Caldiera, S. Bozzoni, C. Codecà, S. Zonato, D. Ferrari, P. Foa
A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer
2009 D. Ferrari, J. Fiore, C. Codecà, G. Di Maria, S. Bozzoni, V. Bordin, S. Caldiera, A. Luciani, S. Zonato, I. Floriani, P. Foa